ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,768Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 103

$475K Total Retail Price of All Prescriptions

Rank: 23 out of 103

410 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 410 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

16% of this provider’s 410 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

0% of this provider’s 10,072 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
LEVOTHYROXINE SODIUM 704 645 1 4
FUROSEMIDE 506 456 2 6
SIMVASTATIN 432 397 3 1
LISINOPRIL 308 283 4 2
HYDROCODONE-ACETAMINOPHEN 297 293 S3 5 3
AMLODIPINE BESYLATE 297 286 5 5
CITALOPRAM HBR 295 274 7 10
OMEPRAZOLE 286 251 8 7
POTASSIUM CHLORIDE 285 272 9 12
SERTRALINE HCL 273 272 10 18
NAMENDA 253 253 11 16
DONEPEZIL HCL 239 238 12 11
METOPROLOL TARTRATE 215 204 13 8
LOSARTAN POTASSIUM 197 185 14 23
WARFARIN SODIUM 147 147 15 9
CARVEDILOL 139 139 16 22
METOPROLOL SUCCINATE 136 136 17 17
TRAMADOL HCL 131 130 18 20
QUETIAPINE FUMARATE 127 123 19 46
ATENOLOL 126 112 20 19
ISOSORBIDE MONONITRATE ER 119 119 21 26
METFORMIN HCL 116 97 22 14
GABAPENTIN 108 107 23 13
CARBIDOPA-LEVODOPA 105 105 24 60
CLOPIDOGREL 100 100 25 28
RISPERIDONE 94 77 26 41
ALENDRONATE SODIUM 92 92 27 25
PAROXETINE HCL 87 87 28 74
MIRTAZAPINE 83 83 29 24
CIPROFLOXACIN HCL 74 74 30 59
RANITIDINE HCL 72 69 31 31
HYDROCHLOROTHIAZIDE 70 70 32 15
PANTOPRAZOLE SODIUM 69 69 33 37
PLAVIX 69 69 33 44
LOVASTATIN 69 56 33 55
FENTANYL 69 69 S2 33 48
TRIAMTERENE-HCTZ 69 69 33 83
MELOXICAM 67 67 38 79
JANUVIA 64 59 39 110
ZOLPIDEM TARTRATE 64 62 39 35
LANTUS SOLOSTAR 63 43 41 93
TAMSULOSIN HCL 58 58 42 30
SEROQUEL 57 57 43 105
ALLOPURINOL 57 55 43 36
FLUTICASONE PROPIONATE 56 44 45 47
TRIAMCINOLONE ACETONIDE 53 40 46 108
AZITHROMYCIN 52 50 47 61
DILTIAZEM HCL 51 39 48 139
PREDNISONE 50 49 49 38
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 13, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.